These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 3945311)

  • 1. The neu oncogene encodes an epidermal growth factor receptor-related protein.
    Bargmann CI; Hung MC; Weinberg RA
    Nature; 1986 Jan 16-22; 319(6050):226-30. PubMed ID: 3945311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185.
    Bargmann CI; Hung MC; Weinberg RA
    Cell; 1986 Jun; 45(5):649-57. PubMed ID: 2871941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A chimeric EGF-R-neu proto-oncogene allows EGF to regulate neu tyrosine kinase and cell transformation.
    Lehväslaiho H; Lehtola L; Sistonen L; Alitalo K
    EMBO J; 1989 Jan; 8(1):159-66. PubMed ID: 2565807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation process induced by epidermal growth factor alters the oncogenic and cellular neu (NGL) gene products.
    Kokai Y; Dobashi K; Weiner DB; Myers JN; Nowell PC; Greene MI
    Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5389-93. PubMed ID: 2899889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen.
    Schechter AL; Stern DF; Vaidyanathan L; Decker SJ; Drebin JA; Greene MI; Weinberg RA
    Nature; 1984 Dec 6-12; 312(5994):513-6. PubMed ID: 6095109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity.
    Stern DF; Heffernan PA; Weinberg RA
    Mol Cell Biol; 1986 May; 6(5):1729-40. PubMed ID: 2878363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor.
    Yamamoto T; Ikawa S; Akiyama T; Semba K; Nomura N; Miyajima N; Saito T; Toyoshima K
    Nature; 1986 Jan 16-22; 319(6050):230-4. PubMed ID: 3003577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodies.
    Drebin JA; Link VC; Stern DF; Weinberg RA; Greene MI
    Cell; 1985 Jul; 41(3):697-706. PubMed ID: 2860972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constitutively activated neu oncoprotein tyrosine kinase interferes with growth factor-induced signals for gene activation.
    Lehtola L; Sistonen L; Koskinen P; Lehväslaiho H; Di Renzo MF; Comoglio PM; Alitalo K
    J Cell Biochem; 1991 Jan; 45(1):69-81. PubMed ID: 1706346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A point mutation in the neu oncogene mimics ligand induction of receptor aggregation.
    Weiner DB; Liu J; Cohen JA; Williams WV; Greene MI
    Nature; 1989 May; 339(6221):230-1. PubMed ID: 2654648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of structure and activation of some receptor-type tyrosine kinase oncogenes.
    Shibuya M; Matsushime H; Yamazaki H; Wang LH; Fukui Y; Ueyama Y; Tamaoki N
    Princess Takamatsu Symp; 1986; 17():195-202. PubMed ID: 3455414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of the early genomic growth factor response in neu oncogene-transformed cells.
    Sistonen L; Koskinen PJ; Lehväslaiho H; Lehtola L; Bravo R; Alitalo K
    Oncogene; 1990 Jun; 5(6):815-21. PubMed ID: 1972791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downstream signal transduction defects that suppress transformation in two revertant cell lines expressing activated rat neu oncogene.
    Reardon DB; Hung MC
    J Biol Chem; 1993 Aug; 268(24):18136-42. PubMed ID: 7688739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The neu gene: an erbB-homologous gene distinct from and unlinked to the gene encoding the EGF receptor.
    Schechter AL; Hung MC; Vaidyanathan L; Weinberg RA; Yang-Feng TL; Francke U; Ullrich A; Coussens L
    Science; 1985 Sep; 229(4717):976-8. PubMed ID: 2992090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A subdomain in the transmembrane domain is necessary for p185neu* activation.
    Cao H; Bangalore L; Bormann BJ; Stern DF
    EMBO J; 1992 Mar; 11(3):923-32. PubMed ID: 1347745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amplification and rearrangement of c-erb B proto-oncogenes in cancer of human female genital tract.
    Zhang X; Silva E; Gershenson D; Hung MC
    Oncogene; 1989 Aug; 4(8):985-9. PubMed ID: 2569708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular cloning of the neu gene: absence of gross structural alteration in oncogenic alleles.
    Hung MC; Schechter AL; Chevray PY; Stern DF; Weinberg RA
    Proc Natl Acad Sci U S A; 1986 Jan; 83(2):261-4. PubMed ID: 3001730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation by EGF is maintained in an overexpressed chimeric EGFR/neu receptor tyrosine kinase.
    Lehväslaiho H; Sistonen L; diRenzo F; Partanen J; Comoglio P; Hölttä E; Alitalo K
    J Cell Biochem; 1990 Mar; 42(3):123-33. PubMed ID: 1969420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural alteration of viral homologue of receptor proto-oncogene fms at carboxyl terminus.
    Coussens L; Van Beveren C; Smith D; Chen E; Mitchell RL; Isacke CM; Verma IM; Ullrich A
    Nature; 1986 Mar 20-26; 320(6059):277-80. PubMed ID: 2421165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neu and its ligands: from an oncogene to neural factors.
    Peles E; Yarden Y
    Bioessays; 1993 Dec; 15(12):815-24. PubMed ID: 7908191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.